PNPLA3 and metabolic dysfunction-associated steatotic liver disease: ,49 Recently, patients with MASLD carrying the PNPLA3 rs738409 polymorphism have been shown to be as insulin resistant as patients with MASLD without the polymorphism at the level of liver, muscle, and adipose tissue.50